B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets
- PMID: 7507125
- DOI: 10.1007/BF00920013
B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets
Abstract
B cell dysregulation is a hallmark of human immunodeficiency virus infection. Since B lymphocytes comprise two distinct subpopulations, CD5+ and CD5- cells, we addressed their individual phenotypic and functional behavior. Seropositive patients with both limited and advanced disease progression had an increased percentage of peripheral blood CD5+ B cells, compared to seronegative controls (20.1 +/- 2.1 and 22.7 +/- 5.7, respectively, vs 17.0 +/- 3.4 in controls); however, due to the lymphopenia and reduced number of circulating B cells in infected individuals, the absolute number of CD19+CD5+ lymphocytes was actually reduced. Although HIV-specific antibodies were synthesized spontaneously in vitro only by CD5- B cells, a 10-fold lower degree of spontaneous, non-HIV-specific activation was also displayed by unstimulated CD5+ B cells. These findings indicate that B cell dysregulation during HIV infection involves both the CD5- and the CD5+ B cell compartments; moreover, in view of the putative role of CD5+ B cells in autoimmune phenomena and IL-10 production, these data reinforce the possibility that B cell dysfunction might be causally involved in AIDS pathogenesis.
Similar articles
-
CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.Clin Immunol Immunopathol. 1993 Mar;66(3):260-8. doi: 10.1006/clin.1993.1034. Clin Immunol Immunopathol. 1993. PMID: 7679344
-
The relationship between CD5+ and CD5- B cells, immunoglobulin-secreting cells (IgSC), and CD4 T cells in human immunodeficiency virus (HIV) infection.Ann N Y Acad Sci. 1992 May 4;651:591-3. doi: 10.1111/j.1749-6632.1992.tb24672.x. Ann N Y Acad Sci. 1992. PMID: 1376087 No abstract available.
-
The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.HIV Med. 2005 Sep;6(5):307-12. doi: 10.1111/j.1468-1293.2005.00312.x. HIV Med. 2005. PMID: 16156877
-
Lymphokine production by B cells from normal and HIV-infected individuals.Ann N Y Acad Sci. 1992 May 4;651:220-7. doi: 10.1111/j.1749-6632.1992.tb24617.x. Ann N Y Acad Sci. 1992. PMID: 1376041 Review.
-
Variable gene usage, physiology and development of Ly-1+ (CD5+) B cells.Curr Opin Immunol. 1992 Apr;4(2):181-5. doi: 10.1016/0952-7915(92)90010-c. Curr Opin Immunol. 1992. PMID: 1376603 Review.
Cited by
-
Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.J Clin Immunol. 1998 May;18(3):235-40. doi: 10.1023/a:1020539207593. J Clin Immunol. 1998. PMID: 9624583
-
The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection.J Immunol Methods. 2007 Mar 30;320(1-2):49-57. doi: 10.1016/j.jim.2006.12.003. Epub 2007 Jan 9. J Immunol Methods. 2007. PMID: 17258763 Free PMC article.
-
An Acquired Factor VIII Inhibitor in a Patient with HIV and HCV: A Case Presentation and Literature Review.Case Rep Hematol. 2013;2013:628513. doi: 10.1155/2013/628513. Epub 2013 Sep 30. Case Rep Hematol. 2013. PMID: 24198984 Free PMC article.
-
Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.Infect Immun. 1995 Sep;63(9):3241-4. doi: 10.1128/iai.63.9.3241-3244.1995. Infect Immun. 1995. PMID: 7543878 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical